Caxton Corporation’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q2
Sell
-1,655
Closed -$221K 18
2016
Q1
$221K Buy
+1,655
New +$221K 0.31% 9